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Abstract
Background: Recent genetic association studies have linked the cadherin-based adherens junction protein
alpha-T-catenin (αT-cat, CTNNA3) with the development of autism. Where αT-cat is expressed in the brain, and
how its loss could contribute to this disorder, are entirely unknown.
Methods: We used the αT-cat knockout mouse to examine the localization of αT-cat in the brain, and we used
histology and immunofluorescence analysis to examine the neurobiological consequences of its loss.
Results: We found that αT-cat comprises the ependymal cell junctions of the ventricles of the brain, and its loss led
to compensatory upregulation of αE-cat expression. Notably, αT-cat was not detected within the choroid plexus, which
relies on cell junction components common to typical epithelial cells. While αT-cat was not detected in neurons of the
cerebral cortex, it was abundantly detected within neuronal structures of the molecular layer of the cerebellum. Although
αT-cat loss led to no overt differences in cerebral or cerebellar structure, RNA-sequencing analysis from wild type versus
knockout cerebella identified a number of disease-relevant signaling pathways associated with αT-cat loss, such as
GABA-A receptor activation.
Conclusions: These findings raise the possibility that the genetic associations between αT-cat and autism may be due to
ependymal and cerebellar defects, and highlight the potential importance of a seemingly redundant adherens junction
component to a neurological disorder.
Keywords: Alpha-T-catenin, Adherens junction, Autism, Alzheimer’s disease, Cerebellum, Choroid plexus, Ependyma,
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Background
The pathogenesis of autism spectrum disorder (ASD) is
complex, likely reflecting interplay between an underlying
genetic predisposition and environmental influence.
Through recent advances in clinical genetic analysis of
those with ASD, many novel genes have been identified as
potentially important mediators of the disorder. One such
gene, αT-catenin (αT-cat, CTNNA3), has been implicated
to be associated with ASD by a large number of independ-
ent genetic analyses [1–9]. Specifically, several genome-
wide association studies have linked single nucleotide poly-
morphisms of αT-cat/CTNNA3 to ASD [1–3]. Moreover,
studies of copy number variants demonstrated that those
with ASD were more likely to have lost the αT-cat/CTNNA3
gene [4–7]. Additionally, αT-cat has been linked to other
neurologic disorders with autistic-like behaviors [8], and a
recent familial study found that compound heterozygote
truncating mutations in αT-cat protein were associated with
ASD [9]. Despite these connections to ASD, the localization
and roles of αT-cat in the brain remain unknown.
α-catenins are essential F-actin-binding proteins of the
cadherin/catenin adhesion complex, the major cell-cell
adhesion system in tissues throughout the body [10].
αE-catenin (αE-cat, CTNNA1) is the most well studied
member of this family, as it is nearly universally
expressed [11]. Mouse knockout studies establish its
requirement for organ structure and function across
various tissue types [12–15]. αT-cat is the most tissue-
restricted and developmentally dispensable member of
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the family, as αT-cat knockout mice are viable and fertile
[16], with expression apparently restricted primarily to
the heart and testis [11]. Interestingly, there is some
evidence that αT-cat may impact other neurologic
diseases, including Alzheimer’s disease (AD) [17–19]
and schizophrenia related to maternal cytomegalo-
virus (CMV)-infection [20, 21]. But despite all these
genetic associations, the majority of research on αT-
cat is limited to its function in cardiomyocytes [16,
22–24] where it is abundantly expressed. While
immunoblot detection of αT-cat has been observed
in the brain [9], the primary cell type and plausible




All experiments using animals were approved by the
Northwestern University IACUC, and the care of experi-
mental animals was in accordance with institutional
guidelines. αT-cat KO C57BL/6 mice (obtained via Dr.
Glenn Radice, Thomas Jefferson University, Philadelphia,
PA) [16] were bred with C57BL/6 WT to create heterozy-
gote, C57BL/6 breeders. WT and αT-cat KO mice used
for experimentation were littermates or descendants from
littermates. They were genotyped using αT-cat-KO spe-
cific primers, which generate separate bands in KO and
WT mice via PCR: F: 5′- TCTATTTTTGAGGCTGTCG-
3′; R: 5′-CAAACTTATGCGTGGTG-3′. αT-cat KO was
confirmed by PCR, distinguishing from heterozygotes,
showing absence of a band generated by WT-specific
primers: F: 5′-CCACCCCTGATATGACCTGTAG-3′; R:
5′-TCCCCAGGAATCAAGTCGTT-3′.
Histology and immunofluorescence
Mice were anesthetized and subjected to intracardiac
perfusion with saline, followed by perfusion of 4 % para-
formaldehyde fixative. Whole brains were removed and
post-fixed in 4 % formaldehyde and embedded in paraf-
fin blocks. For immunofluorescence, tissue sections were
deparaffinized and antigens were retrieved by boiling in
citrate buffer for 30 min. Fluorescent images were cap-
tured using a Zeiss Axioplan epifluorescence microscope.
Primary antibodies used were: BD Biosciences mouse
anti-α-E-catenin (#610193), rabbit anti-α-T-catenin (poly-
clonal #952) [11], rat anti-α-T-catenin (monoclonal, 115
9_12A4S4), Millipore mouse anti-α-T-catenin (MAB20
87), BD Transduction Laboratories mouse anti-E-cadherin
(610182), BD Transduction Laboratories mouse anti-N-
cadherin (#610920), Santa Cruz Biotechnology rabbit
anti-β-catenin (H-102, SC-7199), Millipore rabbit anti-
Connexin-43 (AB1728), Santa Cruz Biotechnology
rabbit anti-p120-catenin (S-19, SC-1101), Santa Cruz
Biotechnology goat anti-δ-catenin (C-20, SC-16512),
Invitrogen mouse anti-ZO-1 (33-9100), Synaptic
Systems rabbit anti GABRA2 (224-103), Santa Cruz
Biotechnology goat anti-doublecortin (C-18, SC-8066),
Dako rabbit anti-GFAP (Z0334), Leica Biosystems rabbit
anti-Ki-67 (NCL-Ki67p), Sigma mouse anti-Tuj1 (T8660),
Swant rabbit anti-Calbindin D28K (CB-38). Secondary
antibodies used were: Alexa Fluor 488/568 goat anti-
mouse/rabbit (Life Technologies) and Alexa Fluor 568
donkey anti-goat (Life Technologies). Tissue processing
was supported by the Northwestern University Mouse
Histology and Phenotyping Laboratory (MHPL) and a
Cancer Center Support Grant (NCI CA060553). H&E
histology was performed by the MHPL.
Western blotting
Whole brains, from mice 7-8 weeks old, were lysed in
T-PER Tissue Protein Extraction Reagent (Thermo-
Fisher) with Protease and Phosphatase Inhibitor Mini
Tablets (Pierce). Tissue was homogenized with tissue
grinder pestle. Cerebral cortex and cerebellum tissue was
carefully dissected to ensure no contamination from
ventricular structures. Samples were run by SDS-PAGE,
then transferred to nitrocellulose membrane. For western
blot, primary antibodies used were: BD Biosciences mouse
anti-α-E-catenin (#610193), rabbit anti-α-T-catenin (poly-
clonal, #952), BD Biosciences mouse anti-N-cadherin (#61
0920), Santa Cruz Biotechnology rabbit anti-β-catenin (H-
102, SC-7199), Santa Cruz Biotechnology mouse anti-δ-
catenin (40.1, SC-81793), Santa Cruz Biotechnology goat
anti-doublecortin (C-18, SC-8066), Cell Signaling rabbit
anti-α-N-catenin (2163S), Alomone rabbit anti-GABRA2
(AGA002), and Sigma mouse anti-beta-tubulin (T4026).
The secondary antibodies were: LI-COR IRDye680 Donkey
anti-rabbit (926-68073) and IRDye800 Donkey anti-mouse
(926-32212). Imaging performed using the Odyssey Infra-
red Imaging System (LI-COR).
Human tissue
No consent was necessary for the human data, as de-
identified human brain tissue was obtained during aut-
opsy, with an exemption granted from the Northwestern
IRB. For both the ependymal and cerebellar tissue, there
was no evidence of pathologic damage to the region.
Tissues were processed using the Robert H. Lurie Com-
prehensive Cancer Center of Northwestern University
Pathology Core Facility.
Immunofluorescence quantification
After staining for α-E-catenin as above, the total fluores-
cent intensity density of exposure-matched images was
measured. This was done by outlining the entirely of the
ependymal cell layer along the visible cellular borders of
the anterior lateral ventricles using ImageJ, and measur-
ing the density of the signal averaged across this area.
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Although the majority of the α-E-catenin signal was
present near the apical junctions of the cells, the entire
ependymal layer was quantified to reduce any potential
bias in quantification. Two measurements were per-
formed per mouse, one for each ventricle in the section of
each coronally sectioned brain tissue. Therefore, for each
group, 6 measurements were performed, with 3 mice per
group. For the quantification of Ki-67 positive cells, the
total numbers of Ki-67 cells were counted from each
ventricular area from coronal H&E-stained sections of the
anterior lateral ventricles. Both ventricles present were
quantified, and the mean of both Ki-67 positive counts
was utilized per mouse for quantification.
Ventricle size quantification
For the quantification of the size of the lateral ventri-
cles, the ventricular lumen area from coronal H&E-
stained sections was quantified using ImageJ. Mice
were age-matched, sex-matched, and were the progeny
of littermates. Only intact lateral ventricles, clearly
adjacent to the hippocampus (as in Fig. 1) were mea-
sured. Because the lateral ventricles from other sec-
tions of the brain, particularly in the anterior lateral
ventricles, showed substantial variability with few
discrete histological landmarks, the perihippocampal
lateral ventricles were chosen for quantification to
minimize potential bias and increase the consistency
of the measurements. If more than one ventricle was in-
tact and visible in the tissue section, the mean of both
ventricles was utilized per mouse for quantification.
RNA isolation
After dissection of the brain, cerebellar tissue (n = 3) was
used for RNA extraction using TRIzol/chloroform dur-
ing homogenation of the fatty brain tissue. Subsequently,
the Aurum Total RNA mini Kit (Bio-rad) was used ac-
cording to the manufacturer’s protocol. RNA dissolved
in elution buffer was frozen to -80 °C and shipped to the
VIB Nucleomics Core (VIB, Belgium) for RNA sequen-
cing by Next Generation Sequencing technology, i.e.
massive parallel sequencing using Illumina Truseq pro-
cedures on an Illumina Hi-Seq apparatus.
Read preprocessing and mapping of RNA-sequencing data
The raw data of FASTQ format were processed to remove
as much technical artifacts as possible. Low quality ends
(phred score <20) were trimmed using the FASTX tool kit
(http://hannonlab.cshl.edu/fastx_toolkit). Adapter trimming
was performed with cutadapt 1.2.1 [25]. Reads shorter than
15 bp after adapter trimming were removed. Quality filter-
ing was done using FastX 0.0.13 and ShortRead 1.16.3 [26].
PolyA-reads (more than 90 % of the bases equal A), am-
biguous reads (containing N), low quality reads (more than
50 % of the bases <Q25) and artifact reads (all but 3 bases
in the read equal one base type) were removed. The
remaining clean reads were aligned against the reference
genome of Mus musculus (mus_musculus_GRCm38.73),
using the TopHat v2.0.8b software [27]. As parameter op-
tions we used: –library-type fr-unstranded –min-intron-
length 50 –max-intron-length 500000 –no-coverage-search
–no-mixed –read-realign-edit-dist 3. Quality filtering (re-
moval of reads that are non-primary mappings or have a
mapping quality < 20), sorting and indexing of the resulting
bam-files were done with samtools 0.1.19 [28].
Identification of differentially expressed genes
Gene expressions of the transcripts were calculated by
counting the number of reads in the alignments that over-
lap with the gene features, using htseq-count 0.5.4p3 [29].
As parameters we took: -m union –stranded = reverse -a 0
-t exon -i gene id. Subsequently, the edgeR 3.12.0 tool [30]
was utilized to detect the differentially expressed genes be-
tween the αT-cat WT and KO samples. The modeling of
the variance for each gene was done using both the com-
mon dispersion model (the same dispersion value is used
for each gene) and the moderated tagwise dispersion
model (a distinct, individual dispersion is estimated and
used for each gene). EdgeR used with the moderated tag-
wise dispersion model tends to rank more highly as DE
genes that are more consistent in their counts within
groups. Finally, genes with a p-value ≤ 0.01, corresponding
to a false discovery rate (FDR) value ≤ 0.3, were considered
as differentially expressed (DE).
Systems biology
The biological interpretation of the DE genes observed
in the WT versus αT-cat KO samples was performed
using QIAGEN’s IngenuityR Pathway Analysis (IPAR,
QIAGEN Redwood City, www.qiagen.com/ingenuity), in
order to identify and characterize biological functions,
canonical pathways and gene networks associated with
these genes. IPA analyses rely on the Ingenuity Pathways
Knowledge Base (IPKB), a manually curated database
containing data extracted from the full text of journals
as well as gene annotation databases and interaction
data from third party databases, such as DIP, IntAct,
MINT, MIPS, BIND and BIOGRID. An IPA (Core) ana-
lysis consists of mapping each gene identifier to its
corresponding gene object (focus gene) in the IPKB, the
generation of networks using the uploaded focus genes
as seeds, identification of the biological processes, dis-
eases, or toxicological functions affected in the experiment
(functional analysis) and identification of the canonical
pathways the experimental dataset may be involved in (ca-
nonical pathways). IPA uses Fisher’s exact test to calculate
a p-value determining the probability that each biological
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Fig. 1 αT-cat is localized to ependymal, but not choroid plexus, epithelial cell junctions. a Double immunofluorescence labeling of the perihippocampal
third ventricle of WT and αT-cat KO mice with antibodies to either αT-cat or αE-cat. αE-cat is found in both ependymal (EP) cell-cell junctions (arrows,
enlarged in white boxes) and choroid plexus (CP) (arrowheads), whereas αT-cat is detected in only ependymal cells. b Immunofluorescence of the lateral
ventricle proximal to the subventricular zone of an adult human. β-catenin is found at ependymal cell-cell junctions with αT-cat (arrows). c
Immunofluorescence staining of αE-cat in the anterior lateral ventricles of WT and αT-cat KO mice, quantified in (d), n = 6. Hoechst-stained
nuclei in blue. *p < 0.05, Student’s t-test. Error bars = S.E.M
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process, disease or toxicological function assigned to the
data set is due to chance alone.
Statistics
Statistical analysis was performed using Student’s t-test,
two-tailed and unpaired, with a p-value of less than 0.05
considered significant. Calculations were performed using
GraphPad Prism software (Graph Pad Software Inc., La
Jolla, CA).
Results and discussion
αT-cat is expressed in the cell-cell junctions of ependymal
cells, but not the choroid plexus
Using littermate matched wild-type (WT) and αT-cat
germline knockout (KO) mice, we carried out immuno-
fluorescence analysis of the brain to determine the pri-
mary αT-cat expressing cell types. In the cerebrum, we
found that αT-cat was predominantly detected in cell-
cell junctions of ependymal cells lining the ventricles in
Fig. 3 Loss of αT-cat does not disrupt proliferation along the SVZ. a Immunofluorescence of the lateral ventricle subventricular zone (SVZ) for Ki-
67, indicating similar regions of proliferation (arrows) between WT and αT-cat KO mice. b Immunofluorescence of doublecortin (Dcx) along the
walls (arrows) of lateral ventricle SVZ. c Quantification of total Ki-67-positive cells along the WT and αT-cat KO mice SVZ (n = 4), with no significant
difference by Student’s t-test. d Western blot of Dcx in whole brain lysate (below) of WT and KO mice (n = 4), with tubulin as a loading control.
e Immunofluorescence of focal regions of the lateral ventricle subventricular zone (SVZ) for Tuj1 (green, immature neurons) and GFAP (red, glial
cells) of WT and αT-cat KO mice.). n.s. = not significant. Hoechst-stained nuclei in blue
Fig. 2 Histologic analysis of lateral ventricle size in WT and αT-cat KO mice. a Coronal, H&E-stained sections of WT and αT-cat KO perihippocampal
lateral ventricles (enlarged in box inset), with quantification of ventricle size in (b), n = 4. *p < 0.05, Student’s t-test. Error bars = S.E.M
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mouse (Fig. 1a). Consistent with this observation, we
confirmed that αT-cat is also present in the ependyma
of human brain (Fig. 1b). Interestingly, αT-cat was not
found in the choroid plexus (CP), the only other simple
cuboidal epithelium present in brain, which instead ex-
presses αE-cat (Fig. 1a). The localization of αT-cat to
cells lining the ventricular-cerebral spinal fluid (CSF)
system raised the possibility that αT-cat might impact
the structure and function of this system. Loss of αT-cat
in ependymal cells was associated with an apparent in-
crease in the abundance of αE-cat (Fig. 1c-d). A similar
increase in αE-cat protein is observed in the hearts of
αT-cat KO mice [16], suggesting that the upregulation
of αE-cat when αT-cat is lost may be a universal com-
pensatory feature of αT-cat loss. While examining the
potential changes to ventricle structure, the perihippo-
campal lateral ventricles appeared mildly enlarged in
αT-cat KO mice based on histologic analysis (Fig. 2a-b).
Although this suggests that αT-cat may control ventricu-
lar size, more robust assays, such as quantitative MRI-
imaging, would need to be performed to definitely test
whether the loss of αT-cat results in any changes to the
ventricular system of the brain.
Because the ependymal cells have a well-defined role
in regulating neurogenesis [31], we next interrogated
differences in the subventricular zone (SVZ) between
WT and αT-cat KO mice. However, we found no differ-
ence in SVZ proliferation, as measured by Ki-67-positive
cells along the walls of the lateral ventricles (Fig. 3a,
quantified in Fig. 3c) between WT and αT-cat KO mice.
Additionally, when we stained for the neurogenesis
marker doublecortin (Dcx), there was no difference
observed between WT and αT-cat KO mice by immuno-
fluorescence (Fig. 3b) or by immunoblot analysis (Fig. 3d).
Finally, WT and αT-cat KO mice also showed similar glial
and immature neuron organization along the lateral
ventricles (Fig. 3e). Overall, the loss of αT-cat appears to
contribute little effect to the regulation of the SVZ, which
is consistent with the lack of gross morphological differ-
ences observed in overall brain structure.
Ependymal cell junctions are morphologically and
compositionally distinct from those of the choroid plexus
αT-cat expression has only previously been shown in mes-
enchymal tissues, such as heart [11], and not in traditional
epithelia that typically express αE-cat. Therefore, we sought
to compare adherens junction protein expression between
ependymal cells and choroid plexus (CP), particularly be-
cause the latter is long considered to be a modified epen-
dymal cell [32]. Interestingly, we found that the junctions of
Fig. 4 Choroid plexus and ependymal cells have distinct cell-cell adhesion components. a Double immunofluorescence of N-cadherin and β-catenin
in the choroid plexus and ependyma, showing a cell adhesion transition zone (TZ, starting at the asterisk) b-f Double or single immunofluorescence
labeling of cell-cell adhesion proteins (p120 catenin and E-cadherin; β-catenin and N-cadherin; connexin-43 and acetylated tubulin, δ-catenin and ZO-
1) in ependymal cells (arrows) and the choroid plexus (arrowheads). Hoechst-stained nuclei in blue
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these epithelia are distinct. When examined by immuno-
fluorescence, there is a transition zone where N-cadherin
expression found in ependymal cells decreases along the
outgrowth of CP [33], whereas β-catenin expression in-
creases (Fig. 4a). CP was further distinguished by classic
epithelial markers, including E-cadherin and p120 catenin
(CTNND1) (Fig. 4b), while αT-cat-expressing ependymal
cell junctions contained N-cadherin and Connexin-43 (Cx-
43) (Fig. 4c-d), Interestingly, δ-catenin (CTNND2), which
has also recently been implicated in autism [34], was de-
tected in both ependymal and CP junctions (Fig. 4e), as was
β-catenin (Fig. 4c) and the tight-junction protein ZO-1
(Fig. 4f). Beyond differences in expression of these junction
proteins, their subcellular localization was also distinct.
While E-cadherin and p120 catenin showed an apicolateral
zonular adherens junction localization in the cells of the
CP, β-catenin and δ-catenin demonstrated a more basolat-
eral staining. Conversely, N-cadherin and β-catenin dis-
played an apicolateral junctional staining pattern in the
ependyma, while δ-catenin marked the apical membrane.
All together, the ependyma is a morphologically true epi-
thelial layer, but is unique in that it expresses traditional
markers of mesenchymal tissue, including N-cadherin and
Cx43. Interestingly, these two components also com-
prise the specialized hybrid adherens junctions αT-cat
forms in cardiomyocytes, coordinating the adherens
and gap junctions, respectively [16]. Beyond under-
standing the junctional diversity of the ependyma and CP,
these unique expression patterns may also be useful tools
in future neurobiology research, as there is currently a
dearth of reliable markers to distinguish the CP from the
ependyma. Unfortunately, even with all of these cell-cell
adhesion proteins found in the ependyma, we could detect
no overt differences between these junctional proteins be-
tween WT and αT-cat KO mice. The adherens and tight
junctions remained intact (Fig. 5), suggesting that the loss
of αT-cat may only have subtle effects on ependymal cell-
cell junctions.
αT-cat is detected in the cerebellar, but not the cerebral,
cortex
We noticed that αT-cat was expressed at relatively low
levels by whole brain immunoblot analysis (Fig. 6a), sug-
gesting its presence in rare cells types of the brain. Con-
sistent with αT-cat’s apparently exclusive localization to
ependymal cells (Fig. 1), no αT-cat was detected in the
cortex of the cerebrum, which was dissected to omit
ventricular ependymal contamination (Fig. 6b). αT-cat
was also not detected in neurons of the cerebrum, al-
though by immunofluorescence analysis there was a false
positive signal in both WT and αT-cat KO mice (Fig. 6d),
which may explain previous reports of αT-cat expression
Fig. 5 Adherens and tight junctions in the ependyma of WT and αT-cat KO mice. a Immunofluorescence of the tight junction protein ZO-1
(shown in green) in the ependyma (shown on right) and choroid plexus (shown on left) of WT and αT-cat KO mice. b High-magnification
images of immunofluorescence of the adherens junction protein β-catenin (shown in red) in the ependyma of WT and αT-cat KO mice.
Hoechst-stained nuclei in blue
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in cortical neurons [35]. Interestingly, αT-cat was ro-
bustly detected by immunoblot of the cerebellar cortex
(also dissected to omit ependymal contamination)(-
Fig. 6b), suggesting its presence in an abundant cell type.
Curiously, while αE-cat expression was dominant in the
cerebral cortex, it was much less abundant in the
cerebellum (Fig. 6b), suggesting that αT-cat and αE-cat
may contribute distinct functions across these brain
compartments. Similar to αE-cat, αN-cat was predomin-
antly expressed in the cerebrum and nearly undetectable
in the cerebellum (Fig. 6c), which indicates that αT-cat
may be the primary α-cat of the cerebellum. Finally, the
loss of αT-cat increased the cerebellar expression of αE-
cat, β-catenin, and δ-catenin, suggesting a potential
compensatory upregulation of these junctional compo-
nents (Fig. 6c).
Importantly, αT-cat was specifically detected within the
molecular- (cellular processes), but not the granular- (cell
bodies), layer of the cerebellum, consistent with previous
data [36] (Fig. 6d). Using human cerebellar tissue, αT-cat,
but not αE-cat, was clearly detected along neurite projec-
tions within the molecular layer (Fig. 6e). Although differ-
ences in junctional protein expression were found by
western blot, overt changes to junctional structures within
the cerebellum were absent between WT and αT-cat KO
mice (Additional file 1: Figure S1). Since the murine
cerebellum did not appear to have the discrete, trad-
itional cell-cell junctions usually visualized by these
proteins, the cerebellar function of the altered cell-
cell junction proteins shown in Fig. 6c could not be
described. While there is some data suggesting that
αT-cat and αE-cat may be able to stabilize dendritic
spines [37], whether this occurs in the cerebellum is
unknown.
Lastly, αT-cat was also found in cell junctions of the
pia-arachnoid surrounding the brain (Fig. 6d), which
is a simple epithelium that lines the sub-arachnoid
space filled with CSF. Since this space is contiguous
with the ventricles lined by ependymal cells, these data
indicate that αT-cat participates in junctions from
Fig. 6 αT-cat is not present in the cerebral cortex, but rather is in the molecular layer of the cerebellum. a Western blot of whole brain lysate of WT and
αT-cat KO mice. b-c Western blot of cerebral cortex and cerebella, dissected without nearby ventricles, of WT and αT-cat KO mice. d Immunofluorescence
of αT-cat in the cerebral cortex and cerebellum in WT and αT-cat KO mice, with false positive signal (arrows) and true positive signal in the molecular layer
and pia mater (arrowheads) of the cerebellum (bottom panels). e Double immunofluorescence of αT-cat and αE-cat in human cerebellum, with positive
αT-cat staining (arrowheads) in the molecular layer. Hoechst-stained nuclei in blue
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simple cuboidal (ependymal) and squamous (pia-
arachnoid) epithelia that line this fluid-filled space.
We next sought to identify which cell types in the
molecular layer of the cerebellum expressed αT-cat.
Neurites from a number of cell types are found in this
layer, including the dendritic trees of the Purkinje cells
and the projections of granular neurons. Using calbin-
din D28K as a marker of Purkinje cells [38], immuno-
fluorescence demonstrated that αT-cat in the human
cerebellum co-localizes with Purkinje cell dendrites
(Fig. 7). Interestingly, αT-cat could also be detected
along neurites not calbindin-positive (Fig. 7), indicating
that αT-cat may be present in a diverse number of cell
types in the cerebellum. Overall, this may be consistent
with previous αT-cat promoter-based β-galactosidase
expression data [36].
RNA sequencing analysis of cerebella implicates αT-cat in
several neurological disease pathways
While there were no overt morphological or cellular
changes found in αT-cat KO mice cerebella when com-
pared to WT, we suspect that the upregulation of cell
adhesion proteins in the absence of αT-cat (Fig. 6c)
compensates for this loss, as both αE-cat and αT-cat
may share similar neural functions [37]. To assess more
subtle changes due to the loss of αT-cat that may be
relevant to neurological diseases, we performed an
RNA-sequencing (RNA-seq) analysis between WT and
αT-cat KO mouse cerebella. From this, we discovered a
number of gene transcripts altered by the loss of αT-cat,
from which we associated with several neurologic disease-
relevant pathways. The complete RNA-seq dataset shows
these results in complete detail (see Additional file 2).
Fig. 7 αT-cat is present in diverse cell types in the molecular layer of the cerebellum. Double Immunofluorescence of αT-cat (shown in green) and
calbindin D28K (shown in red, marker of Purkinje cells) in human cerebellum, at low (shown on left) and high (shown on right) magnifications. Areas of
both co-localization of αT-cat and calbindin staining (arrows) and of αT-cat staining alone (arrowheads) can be observed within the molecular layer.
Hoechst-stained nuclei in blue
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Notable among these were two pathways previously
implicated in ASD, including amyloid-β precursor protein
APP [39] and estrogen (ESR1) [40] (Additional file 1:
Figure S2). Interestingly, the loss αT-cat was associated
with changes to a number of other hormone signaling
pathways, including corticotropin (CRH) [41] and soma-
tostain (SST) [42], which have also been previously associ-
ated with ASD. The cerebellum is not the canonical
secretion site for any of these hormones, so αT-cat’s influ-
ence on them remains a mystery. One possible hypothesis
may be that αT-cat regulates either local production or
signaling of these hormones, but further research will
need to be conducted to ultimately test this. Finally, not-
able among the top identified genes influenced by αT-cat
was MEIS2 [43], which has also associated with ASD. Im-
portantly, for all of these genes identified by the RNA-seq
analysis, each will need to be validated by future experi-
ments to definitively link their expression to αT-cat.
Accordingly, we have validated the top associated gene
identified by the RNA-sequencing analysis: GABRA2,
which encodes GABA-A receptor α2. From the RNA-seq
data described above, gene expression of GABRA2 in αT-
cat KO cerebella was increased when compared to WT.
Consistent with this finding, immunoblot of GABA-A
receptor α2 showed increased expression in αT-cat KO
mouse cerebella (Fig. 8a). Furthermore, we performed im-
munofluorescence of WT and αT-cat KO cerebella. Inter-
estingly, the αT-cat KO cerebellum appeared to show an
increase in GABA-A receptor α2 expression, primarily
within the granular layer (Fig. 8b-c). The role GABA-A
receptor α2 may be playing in the granular layer, but how
it may directly or indirectly relate to the function of αT-
cat, remains unknown. However, previous studies have
demonstrated that altered expression of GABA-A receptor
α2 has been associated with both autism [44] and schizo-
phrenia [45], suggesting that αT-cat may participate in a
shared pathogenesis.
αT-cat may be linked to neurologic diseases through its
ependymal and cerebellar functions
We have shown that αT-cat in the brain is expressed in
ependymal cells and the neuronal processes within the
Fig. 8 GABA-A receptor α2 expression is increased in the αT-cat KO cerebellum. a Immunoblot of WT and αT-cat KO cerebella for the GABA-A
receptor α2, with tubulin as a loading control. b Immunofluorescence of WT and αT-cat KO mouse cerebella for GABA-A receptor α2 (shown in red),
at a low magnification, with a higher magnification shown in (c). At both magnifications, more GABA-A receptor α-2 expression can be observed in
the granular layer of the cerebellum (arrowheads). Hoechst-stained nuclei in blue
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molecular layer of the cerebellum. A common feature of
these distinct cell types may be their proximity to mech-
anical stressors, consistent with αT-cat’s function in heart.
For example, the ependyma and pia-arachnoid are subject
to CSF-flow [46], and the granular neurons of the cerebel-
lum are considered to withstand substantial mechanical
forces during development to generate stereotypic cere-
bellar folds [47]. These region-specific localizations of αT-
cat may also have implications for the many genetic
linkages between αT-cat and disease. The role of the cere-
bellum in the development of autism is well defined [48],
and our data suggest that αT-cat may play an important
role in regulating the cell junction components in neurite
structures or cell signaling within the cerebellum. Because
we did not detect αT-cat in neurons of the cerebral cortex,
and αT-cat KO mice demonstrate no overt neurologic
dysfunction, we suspect there is no direct neuronal link of
αT-cat dysfunction to the established, neuronal etiologies
of ASD, or even AD, such as neurofibrillary tangles or
amyloid plaques [49]. However, there is evidence that
enlarged ventricles are associated with late-onset AD
[50], as well as ASD [51]. Whether this is a secondary
effect of neural loss or an independent driver of dis-
ease remains unknown, but our evidence that αT-cat
comprises the junctions that line ventricles raises the
formal possibility that an underlying ependymal bar-
rier defect may contribute to ventricular dysfunction
in humans. This may also explain why αT-cat poly-
morphisms were only associated with sporadic, late-
onset AD [17] rather than familial AD. Furthermore,
although ASD and AD represent diseases that differ
significantly in pathogenesis, our data add to the
growing evidence of shared biochemical pathways,
particularly in the cerebellum, that link these diseases
[52]. Lastly, our finding of αT-cat in ependymal junctions
may explain αT-cat’s connection to maternal CMV infec-
tion and schizophrenia [20, 21]. Because neonatal CMV
primarily infects the ependymal layer [53], and ventricle
enlargement has long been associated with schizophrenia
[54], αT-cat ependymal junction dysfunction might affect
susceptibility to CMV infection and subsequent develop-
ment of schizophrenia.
Conclusions
In summary, we show that αT-cat is expressed in epen-
dymal epithelial cells and cellular processes within the mo-
lecular layer of the cerebellum, and propose how alteration
of these structures may rationalize the various genetic asso-
ciations between αT-cat and ASD, AD and schizophrenia.
Our work also highlights the emerging importance and
disease-relevance of this understudied α-cat family member,
which has been long considered to be a redundant, non-
essential component of adherens junctions.
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Additional file 1: Figure S1: Localization of β-catenin in the cerebella of
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Hoechst-stained nuclei in blue. Figure S2. Interaction networks of differentially
expressed genes in αT-cat KO vs. WT cerebellum. Two interaction networks
were developed from APP and ESR1-relevant genes identified from the RNA-
seq analysis. Predicted downregulated transcripts are in teal, upregulated
transcripts are in red, and downregulated transcripts in green (color intensity
reflects fold change). Blue lines indicate upregulation, gray lines indicate
downregulation, and yellow lines indicate inconsistency between findings and
database. Full lines show direct interactions, and dashed lines show indirect
interactions. (PDF 1561 kb)
Additional file 2: Full αT-cat KO vs. WT RNA-sequencing results and analysis
(Additional File 1.xls). This file contains the list of genes identified by the
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disease relevant pathways implicated by those genes identified. (XLS 454 kb)
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